alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 21.1
 SUBSIDIARIES OF AMBASSADORS INTERNATIONAL, INC.
 1.
    
    Ambassadors, LLC, a Delaware limited liability company, a wholly-owned subsidiary of
Ambassadors International, Inc.2.
    
    Ambassadors Cruise Group, LLC, a Delaware limited liability company, a wholly-owned
subsidiary of Ambassadors International, Inc.3.
    
    American West Steamboat Company, LLC, an Oregon limited liability company, a wholly-owned
subsidiary of Ambassadors Cruise Group, LLC4.
    
    EN Boat LLC, an Oregon limited liability company, a wholly-owned subsidiary of Ambassadors
Cruise Group, LLC5.
    
    QW Boat Company LLC, an Oregon limited liability company, a wholly-owned subsidiary of
Ambassadors Cruise Group, LLC6.
    
    DQ Boat, LLC, a Delaware limited liability company, a wholly-owned subsidiary of Ambassadors
Cruise Group, LLC7.
    
    AQ Boat, LLC, a Delaware limited liability company, a wholly-owned subsidiary of Ambassadors
Cruise Group, LLC8.
    
    MQ Boat, LLC, a Delaware limited liability company, a wholly-owned subsidiary of Ambassadors
Cruise Group, LLC9.
    
    Ambassadors International Cruise Group (USA), LLC, a Delaware limited liability company, a
wholly-owned subsidiary of Ambassadors International Cruise Group, LLC10.
    
    Ambassadors International Marshall Islands, a Marshall Islands limited liability company, a
wholly-owned subsidiary of Ambassadors Cruise Group, LLC11.
    
    Ambassadors International Cruise Group LLC, a Marshall Islands limited liability company, a
wholly-owned subsidiary of Ambassadors International Marshall Islands, LLC12.
    
    Ambassadors International Cruise Group, LLC, a Marshall Islands limited liability company, a
wholly-owned subsidiary of Ambassadors International Marshall Islands, LLC13.
    
    Windstar Sail Cruises Limited, a Bahamas company, a wholly-owned subsidiary of Ambassadors
International Cruise Group, LLC14.
    
    Wind Spirit Limited, a Bahamas company, a wholly-owned subsidiary of Windstar Sail Cruises
Limited15.
    
    Wind Star Limited, a Bahamas company, a wholly-owned subsidiary of Windstar Sail Cruises
Limited16.
    
    Degrees Limited, a Bahamas company, a wholly-owned subsidiary of Windstar Sail Cruises
Limited17.
    
    Ambassadors International Investments, LLC, a Marshall Islands company, a wholly-owned
subsidiary of Ambassadors International Cruise Group, LLC18.
    
    CQ Boat, LLC, a Delaware limited liability company, a wholly-owned subsidiary of Ambassadors
Cruise Group, LLC19.
    
    Contessa Boat, LLC, a Delaware limited liability company, a wholly-owned subsidiary of
Ambassadors Cruise Group, LLC
Editorial Note on Part 882
Editorial Note: Nomenclature changes to part 882 appear at 73 FR 35341, June 23, 2008.

§ 882.4125 Neurosurgical chair. ( a ) *Identification.* A neurosurgical chair is an operating room chair used to position and support a patient during neurosurgery.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 882.9.
[44 FR 51730, Sept. 4, 1979, as amended at 59 FR 63012, Dec. 7, 1994; 66 FR 38808, July 25, 2001]
Editorial Note on Part 872
Editorial Note: Nomenclature changes to part 872 appear at 73 FR 35341, June 23, 2008.

§ 872.1800 Extraoral source x-ray system. ( a ) *Identification.* An extraoral source x-ray system is an AC-powered device that produces x-rays and is intended for dental radiographic examination and diagnosis of diseases of the teeth, jaw, and oral structures. The x-ray source (a tube) is located outside the mouth. This generic type of device may include patient and equipment supports and component parts.
( b ) *Classification.* Class II.
I 

118TH CONGRESS 

2D SESSION H. R. 7418 

To amend the Internal Revenue Code of 1986 to exclude from gross income 

certain compensation to clinical trial participants. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 20, 2024 

Mr. KELLY of Pennsylvania (for himself and Ms. HOULAHAN) introduced the 

following bill; which was referred to the Committee on Ways and Means 

A BILL 

To amend the Internal Revenue Code of 1986 to exclude 

from gross income certain compensation to clinical trial 

participants. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. EXCLUSION OF COMPENSATION PROVIDED TO 

4 PARTICIPANTS IN CLINICAL TRIALS. 

5 (a) IN GENERAL.—Part III of subchapter B of chap6 ter 1 of the Internal Revenue Code of 1986 is amended 

7 by inserting after section 139I the following new section: 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•HR 7418 IH

1 ‘‘SEC. 139J. CLINICAL TRIAL PAYMENTS. 

2 ‘‘(a) IN GENERAL.—Gross income shall not include 

3 any amount received by an individual as a qualified clinical 

4 trial payment. 

5 ‘‘(b) QUALIFIED CLINICAL TRIAL PAYMENT DE6 FINED.—For purposes of this section, the term ‘qualified 

7 clinical trial payment’ means any amount paid to an indi8 vidual— 

9 ‘‘(1) as compensation for participation by the 

10 individual or a dependent of the individual in an ap11 proved clinical trial, or 

12 ‘‘(2) to reimburse or pay reasonable and nec13 essary expenses incurred in connection with partici14 pation by the individual or a dependent of the indi15 vidual in an approved clinical trial. 

16 ‘‘(c) OTHER DEFINITIONS.—For purposes of this 

17 section— 

18 ‘‘(1) APPROVED CLINICAL TRIAL.—The term 

19 ‘approved clinical trial’ has the meaning given such 

20 term in section 2709(d)(1) of the Public Health 

21 Service Act (42 U.S.C. 300gg–8(d)(1)), determined 

22 by applying ‘disease or condition’ for ‘life-threat23 ening disease or condition’. 

24 ‘‘(2) DEPENDENT.—The term ‘dependent’ has 

25 the meaning given such term in section 152.’’. 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
3 

•HR 7418 IH

1 (b) CLERICAL AMENDMENT.—The table of sections 

2 for part III of subchapter B of chapter 1 of such Code 

3 is amended by inserting after the item relating to section 

4 139I the following new item: 

‘‘Sec. 139J. Clinical trial payments.’’. 

5 (c) EFFECTIVE DATE.—The amendment made by 

6 this section shall apply to amounts paid after December 

7 31, 2023. 

Æ 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
Editorial Note on Part 870
Editorial Note: Nomenclature changes to part 870 appear at 73 FR 35341, June 23, 2008.

§ 870.2330 Echocardiograph. ( a ) *Identification.* An echocardiograph is a device that uses ultrasonic energy to create images of cardiovascular structures. It includes phased arrays and two-dimensional scanners.
( b ) *Classification.* Class II (performance standards).
Editorial Note on Part 886
Editorial Note: Nomenclature changes to part 886 appear at 73 FR 35341, June 23, 2008.

§ 886.5916 Rigid gas permeable contact lens. ( a ) *Identification.* A rigid gas permeable contact lens is a device intended to be worn directly against the cornea of the eye to correct vision conditions. The device is made of various materials, such as cellulose acetate butyrate, polyacrylate-silicone, or silicone elastomers, whose main polymer molecules generally do not absorb or attract water.
( b ) *Classification.* ( 1 ) Class II if the device is intended for daily wear only.
( 2 ) Class III if the device is intended for extended wear.
( c ) *Date PMA or notice of completion of a PDP is required.* As of May 28, 1976, an approval under section 515 of the act is required before a device described in paragraph (b)(2) of this section may be commercially distributed. See § 886.3.
[52 FR 33355, Sept. 2, 1987, as amended at 59 FR 10284, Mar. 4, 1994]
```

[House Report 115-126]
[From the U.S. Government Publishing Office]

115th Congress   }                                       {      Report
                        HOUSE OF REPRESENTATIVES
 1st Session     }                                       {     115-126

======================================================================

 
 PROVIDING FOR CONSIDERATION OF THE BILL (H.R. 115) TO AMEND TITLE 18, 
 UNITED STATES CODE, TO PROVIDE ADDITIONAL AGGRAVATING FACTORS FOR THE 
   IMPOSITION OF THE DEATH PENALTY BASED ON THE STATUS OF THE VICTIM

                                _______
                                

May 16, 2017.--Referred to the House Calendar and ordered to be printed

                                _______
                                

                Mr. Buck, from the Committee on Rules, 
                        submitted the following

                              R E P O R T

                       [To accompany H. Res. 323]

    The Committee on Rules, having had under consideration 
House Resolution 323, by a nonrecord vote, report the same to 
the House with the recommendation that the resolution be 
adopted.

                SUMMARY OF PROVISIONS OF THE RESOLUTION

    The resolution provides for consideration of H.R. 115, the 
Thin Blue Line Act, under a closed rule. The resolution 
provides one hour of debate equally divided and controlled by 
the chair and ranking minority member of the Committee on the 
Judiciary. The resolution waives all points of order against 
consideration of the bill. The resolution provides that an 
amendment in the nature of a substitute consisting of the text 
of Rules Committee Print 115-17 shall be considered as adopted 
and the bill, as amended, shall be considered as read. The 
resolution waives all points of order against provisions in the 
bill, as amended. The resolution provides one motion to 
recommit with or without instructions.

                         EXPLANATION OF WAIVERS

    Although the resolution waives all points of order against 
consideration of the bill, the Committee is not aware of any 
points of order. The waiver is prophylactic in nature.
    Although the resolution waives all points of order against 
provisions in the bill, as amended, the Committee is not aware 
of any points of order. The waiver is prophylactic in nature.

                                  [all]
```
Editorial Note on Part 73
Editorial Note: Nomenclature changes to part 73 appear at 66 FR 66742, Dec. 27, 2001.

§ 73.2575 Titanium dioxide. ( a ) *Identity and specifications.* The color additive titanium dioxide shall conform in identity and specifications to the requirements on § 73.575 (a)(1) and (b).
( b ) *Uses and restrictions.* The color additive titanium dioxide may be safely used in cosmetics, including cosmetics intended for use in the ara of the eye, in amounts consistent with good manufacturing practice.
( c ) *Labeling requirements.* The color additive and any mixtures prepared therefrom intended solely or in part for coloring purposes shall bear, in addition to any other information required by law, labeling in accordance with the provisions of § 70.25 of this chapter.
( d ) *Exemption from certification.* Certification of this color additive is not necessary for the protection of the public health, and therefore batches thereof are exempt from certification pursuant to section 721(c) of the act.
IB 

Union Calendar No. 420 

118TH CONGRESS 

2D SESSION H. R. 7589 

[Report No. 118–505] 

To direct the Secretary of Commerce, acting through the Assistant Secretary 

of Commerce for Communications and Information, to conduct a study 

of the national security risks posed by consumer routers, modems, and 

devices that combine a modem and router, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 8, 2024 

Mr. LATTA (for himself and Mrs. PELTOLA) introduced the following bill; 

which was referred to the Committee on Energy and Commerce 

MAY 14, 2024 

Committed to the Committee of the Whole House on the State of the Union 

and ordered to be printed 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•HR 7589 RH

A BILL 

To direct the Secretary of Commerce, acting through the 

Assistant Secretary of Commerce for Communications 

and Information, to conduct a study of the national 

security risks posed by consumer routers, modems, and 

devices that combine a modem and router, and for other 

purposes. 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
3 

•HR 7589 RH

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Removing Our Unse5 cure Technologies to Ensure Reliability and Security Act’’ 

6 or the ‘‘ROUTERS Act’’. 

7 SEC. 2. STUDY OF NATIONAL SECURITY RISKS POSED BY 

8 CERTAIN ROUTERS AND MODEMS. 

9 (a) IN GENERAL.—The Secretary shall conduct a 

10 study of the national security risks posed by consumer 

11 routers, modems, and devices that combine a modem and 

12 router that are designed, developed, manufactured, or sup13 plied by persons owned by, controlled by, or subject to the 

14 influence of a covered country. 

15 (b) REPORT TO CONGRESS.—Not later than 1 year 

16 after the date of the enactment of this Act, the Secretary 

17 shall submit to the Committee on Energy and Commerce 

18 of the House of Representatives and the Committee on 

19 Commerce, Science, and Transportation of the Senate a 

20 report on the results of the study conducted under sub21 section (a). 

22 (c) DEFINITIONS.—In this section: 

23 (1) COVERED COUNTRY.—The term ‘‘covered 

24 country’’ means a country specified in section 

25 4872(d)(2) of title 10, United States Code. 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
4 

•HR 7589 RH

1 (2) SECRETARY.—The term ‘‘Secretary’’ means 

2 the Secretary of Commerce, acting through the As3 sistant Secretary of Commerce for Communications 

4 and Information. 


kjohnson on DSK7ZCZBW3PROD with $$_JOB

kjohnson on DSK7ZCZBW3PROD with $$_JOB
Union Calendar No. 420 

118TH CONGRESS 

2D SESSION H. R. 7589 

[Report No. 118–505] 

A BILL 

To direct the Secretary of Commerce, acting 

poses. bine a modem and router, and for other pursumer routers, modems, and devices that comstudy of the national security risks posed by conCommunications and Information, to conduct a through the Assistant Secretary of Commerce for 

MAY 14, 2024 

Committed to the Committee of the Whole House on the 

State of the Union and ordered to be printed 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7983 Introduced in House (IH)]

<DOC>

118th CONGRESS
  2d Session
                                H. R. 7983

  To amend the Internal Revenue Code of 1986 to define the term free 
       trade agreement for purposes of the clean vehicle credit.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             April 15, 2024

Mrs. Fischbach introduced the following bill; which was referred to the 
                      Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
  To amend the Internal Revenue Code of 1986 to define the term free 
       trade agreement for purposes of the clean vehicle credit.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Stop Executive Overreach on Trade 
Agreements''.

SEC. 2. FREE TRADE AGREEMENT DEFINED FOR PURPOSES OF CLEAN VEHICLE 
              CREDIT.

    (a) In General.--Section 30D(e)(1) of the Internal Revenue Code of 
1986 is amended by adding at the end the following new subparagraph:
                    ``(C) Free trade agreement.--For purposes of 
                subparagraph (A)(i)(II), the term `free trade 
                agreement' means an international agreement approved by 
                Congress that eliminates duties and other restrictive 
                regulations of commerce on substantially all the trade 
                between the United States and 1 or more other 
                countries.''.
    (b) Effective Date.--The amendment made by this subsection shall 
apply to vehicles placed in service after the date of the enactment of 
this Act.
                                 <all>
```
Editorial Note on Part 880
Editorial Note: Nomenclature changes to part 880 appear at 73 FR 35341, June 23, 2008.

§ 880.5400 Neonatal incubator. ( a ) *Identification.* A neonatal incubator is a device consisting of a rigid boxlike enclosure in which an infant may be kept in a controlled environment for medical care. The device may include an AC-powered heater, a fan to circulate the warmed air, a container for water to add humidity, a control valve through which oxygen may be added, and access ports for nursing care.
( b ) *Classification.* Class II (performance standards).
NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit

2009-1255

TONY COLIDA,

Plaintiff-Appellant,

v.

PANASONIC CORPORATION OF NORTH AMERICA

and MATSUSHITA ELECTRONIC CORPORATION OF AMERICA,

Defendants-Appellees.

Appeal from the United States District Court for the District of New Jersey in

case no. 05-CV-5527, Judge Joseph A. Greenaway, Jr.,

and Magistrate Judge Madeline C. Arleo.

ON MOTION

Before BRYSON, Circuit Judge.

ORDER

Tony Colida submits a motion for leave to proceed in forma pauperis on appeal.

It appears that Colida is attempting to appeal a district court order denying his

motion to reopen his case and denying his motion for leave to proceed in forma

pauperis in that court. With his notice of appeal, Colida also submitted to the district

court a motion to extend or reopen the time to file an appeal. It appears that the district

court has not ruled on the motion to extend or reopen the time to file an appeal. If the

district court does not extend or reopen the time to file an appeal, then Colida's appeal

is clearly untimely.
We also note that, before moving for leave to proceed in forma pauperis in this

court, Colida must file with the district court a motion for leave to proceed in forma

pauperis on appeal. Fed. R. App. P. 24(a)(1). If the district court grants the motion,

then Colida may proceed in forma pauperis in this court on appeal. If the district court

denies the motion, then within 30 days of the district court's order denying his request to

proceed in forma pauperis on appeal, Colida may request that this court permit him to

proceed in forma pauperis on appeal and must include a copy of the district court's

order. Fed. R. App. P. 24(a)(5).

Accordingly,

IT IS ORDERED THAT:

The briefing schedule is stayed for 60 days, to allow time for the district

court to decide Colida's motion to extend or reopen the time to appeal. Either party

should promptly inform this court if the district court acts on the motion.

Colida's motion for leave to proceed in forma pauperis is rejected. Colida

must pay the docketing fee within 30 days of the date of filing of this order, unless he

notifies this court that he has moved for leave to proceed in forma pauperis on appeal

in the district court.

FOR THE COURT

JUN 11 2009

/s/ Jan Horbaly

Date Jan Horbaly

Clerk U.S. eau

THE F

cc:	Tony Colida

Peter J. Pizzi, Esq.

United States District Court, District of New Jersey, Judge

s8

JUN 1 1 2009

nth-lemur

CLERK

2009-1255	2
§ 520.390b Chloramphenicol capsules. ( a ) *Specifications.* Each capsule contains 50, 100, 250, or 500 milligrams (mg) chloramphenicol.
( b ) *Sponsors.* See Nos. 050057 and 054771 in § 510.600(c) of this chapter for use as in paragraph (d) of this section.
( c ) *Special considerations.* Federal law prohibits the extralabel use of this product in food-producing animals.
( d ) *Conditions of use in dogs* — ( 1 ) *Amount.* 25 mg per pound of body weight every 6 hours.
( 2 ) *Indications for use.* For treatment of bacterial pulmonary infections, bacterial infections of the urinary tract, bacterial enteritis, and bacterial infections associated with canine distemper caused by susceptible organisms.
( 3 ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[70 FR 75398, Dec. 20, 2005, as amended at 73 FR 18442, Apr. 4, 2008; 75 FR 55676, Sept. 14, 2010; 79 FR 28819, May 20, 2014]
Exhibit 15.2

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation
by reference in Registration Statement No. 333-207355 on Form F-3 of our report dated 24 February 2016, relating to the consolidated financial statements
(before retrospective adjustments to the financial statement disclosures discussed in Note 46 to the consolidated financial statements) of Santander UK Group Holdings plc and subsidiaries, and to the reference to us under the heading Selected
Financial Data appearing in this Annual Report on Form 20-F of Santander UK Group Holdings plc for the year ended 31 December 2016.



|                      
|----------------------
|/s/ DELOITTE LLP      
|London, United Kingdom
|1 March, 2017
#### CICHON *v.*WOLFF.

Neghtgenoe — Shows — Tithe — Ownership of Amusement — Evidence.

Evidence, in an action for personal injuries sustained on a roller coaster, that, one of the defendants was present, that the amusement park was called hy his name and he assisted in starting the car in which plaintiff rode, was insufficient to prove the ownership of defendant copartnership.

Error to Wayne; Donovan, J.

Submitted April 15, 1915.

(Docket No. 126.)

Decided June 7, 1915.

Case by Mary Cichon against Samuel Wolff and another for personal injuries. Judgment for plaintiff. Defendants bring error.

Reversed.

*A. W. Sempliner,*for appellants.

*Samuel H. Crowl,*for appellee.

Ostrander, J.

The action is trespass on the case to recover damages for personal injuries which plaintiff claims to have received while riding on a roller coaster, so called, at a certain place of amusement in the city of Detroit June 24, 1906. In her declaration plaintiff describes defendants as copartners doing business as Wolff & Son, alleges that the defendants owned, controlled, and operated the said roller coaster, and that, paying a sum of money charged therefor, she accepted their invitation to ride, and rode, thereon. Defendants offered no testimony, but moved for a directed verdict, assigning, among other reasons, that no testimony had been introduced tending to prove that defendants owned, controlled, or operated the roller coaster. The motion was denied. *332The ruling is assigned as error. It does not appear that any exceptions were taken at the trial. Request was made for an instruction that the jury must be satisfied by a preponderance of the evidence that Wolff & Son was a partnership and owned, controlled, and operated the roller coaster. This the court did not give and said nothing to the jury upon the subject. The record contains the substance of all the testimony given upon the trial, as appears by the certificate of the trial judge. It doés not disclose more to connect either defendant with the occurrence than this, that Maurice Wolff was there, that the place was called Wolff’s Park, and that Maurice personally had something to do with starting the car in which plaintiff took her ride. It is contended, also, there is no testimony tending to prove the negligence of either defendant. There appears to be ground for this contention.

We are impressed that, in view of the state of the record, we should not attempt to decide whether from the testimony the negligence of defendants may be inferred, if they in fact owned, controlled, and operated the roller coaster, inviting the public, for a consideration, to ride thereon. The trial judge should at least have given the above indicated instruction.

The judgment is reversed, and a new trial ordered.

Brooke, C. J., and McAlvay; Kuhn, Stone, Bird, Moore, and Steere, JJ., concurred.